Collagenase clostridium histolyticum: a novel nonoperative treatment for Dupuytren’s disease

Article Details

Citation

Copy to clipboard

Andrew J Watt, Vincent R Hentz

Collagenase clostridium histolyticum: a novel nonoperative treatment for Dupuytren’s disease

Int. J. Clin. Rheumatol..

PubMed ID

Not Available

Abstract

Not Available

DrugBank Data that Cites this Article

Drugs

Collagenase clostridium histolyticum

Drug Interactions

• Approved
• Vet approved
• Nutraceutical
• Illicit
• Withdrawn
• Investigational
• Experimental
• All Drugs

Drugs	Interaction
Integrate drug-drug interactions in your software
Collagenase clostridium histolyticum Doxycycline	The therapeutic efficacy of Collagenase clostridium histolyticum can be decreased when used in combination with Doxycycline.
Collagenase clostridium histolyticum Lymecycline	The therapeutic efficacy of Collagenase clostridium histolyticum can be decreased when used in combination with Lymecycline.
Collagenase clostridium histolyticum Clomocycline	The therapeutic efficacy of Collagenase clostridium histolyticum can be decreased when used in combination with Clomocycline.
Collagenase clostridium histolyticum Tigecycline	The therapeutic efficacy of Collagenase clostridium histolyticum can be decreased when used in combination with Tigecycline.
Collagenase clostridium histolyticum Oxytetracycline	The therapeutic efficacy of Collagenase clostridium histolyticum can be decreased when used in combination with Oxytetracycline.